Smart investment of virus RNA testing resources to enhance Covid-19 mitigationCovid-19 완화를 강화하기 위한 바이러스 RNA 테스트 리소스의 현명한 투자Research Article Published on 2021-11-302022-09-12 Journal: PLoS ONE [Category] MERS, 진단, [키워드] addition Antigen applied Asymptomatic average benefit company country COVID-19 pandemic disease spread effective ENhance exchange feasible fraction groups include Intensive Local pandemic PCR assay PCR assays positive test result predict preventing disease principle problem public health reduce reduction Reproduction number resource scenario School SmaRT social distancing Social distancing measure social distancing measures Spread subgroup subgroups suggested symptomatic cases test result tested the epidemic variety Viral RNA virus virus RNA [DOI] 10.1371/journal.pone.0259018 PMC 바로가기 [Article Type] Research Article
Within- and across-day patterns of interplay between depressive symptoms and related psychopathological processes: a dynamic network approach during the COVID-19 pandemicResearch Article Published on 2021-11-302022-10-28 Journal: BMC Medicine [Category] Coronavirus, MERS, SARS, [키워드] addition amplification approach association component concerning conducted COVID-19 pandemic Daily Depression depressive depressive symptom Depressive symptoms detrimental Dynamic network analysis Effect exhibited General adult population greater helplessness identify impacted implication indication individual Intensive Interaction investigated involved lethargy longitudinal study mechanism mechanisms network analysis Nomothetic time series analysis observation pandemic predicted proximal Psychopathological mechanisms Regulation repeated measure required response Result supplementary material susceptible symptoms of depression these symptom [DOI] 10.1186/s12916-021-02179-y PMC 바로가기 [Article Type] Research Article
Admission criteria in critically ill COVID-19 patients: A physiology-based approachResearch Article Published on 2021-11-292022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, [키워드] absence Admissions Analysis analyzed approach Confusion correlation COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 patients criteria Critical Critically ill cut-off Cutoff DNR Dyspnea eligible evaluated ICU ICU admission Intensive intensive care interval limitation management material Mental mortality rate no correlation outcome outcomes oxygen pandemic Patient presenting protocol reduce remained required resources Result retrospective secondary survival rate threshold were excluded [DOI] 10.1371/journal.pone.0260318 PMC 바로가기 [Article Type] Research Article
Investigation of a COVID-19 Outbreak and Its Successful Containment in a Long Term Care Facility in QatarPublic Health Published on 2021-11-262022-10-31 Journal: Frontiers in Public Health [Category] COVID-19, MERS, SARS, [키워드] age Artery average blood glucose Care case sery Comorbidities Comorbidity Compliance Contact tracing Containment Coronary COVID-19 COVID-19 complications COVID-19 outbreak COVID-19 positive patient Deceased develop effective elderly elderly patients Evidence facility females Infection infection control Infection prevention Intensive investigation Long long term care lung management material measure outbreak pandemic Patient patients persistent Personal protective equipment prevention preventive measure protocol Qatar radiological recommendation retrospective Seven symptomatic term the patient Treatment were assessed [DOI] 10.3389/fpubh.2021.779410 PMC 바로가기 [Article Type] Public Health
Italian Society of Anesthesia, Analgesia, Resuscitation, and Intensive Care expert consensus statement on the use of lung ultrasound in critically ill patients with coronavirus disease 2019 (ITACO)Original Article Published on 2021-11-242022-10-30 Journal: Journal of Anesthesia, Analgesia and Critical Care [Category] COVID-19, [키워드] agreement Analgesia Anesthesia anesthesiologist applied chest imaging Clinical management concerning Consensus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 diagnosis COVID-19 patient COVID-19 patients Critically ill Critically ill patient DelPhi Delphi method early diagnosis Evidence expiratory group ICU Intensive intensive care Invasive mechanical ventilation Italian lung Lung ultrasound management patients with COVID-19 physician positive produced Prone position question radiologic reached required Result Resuscitation Society supplementary material the median Ultrasound Ventilator-associated pneumonia working [DOI] 10.1186/s44158-021-00015-6 PMC 바로가기 [Article Type] Original Article
Clinical Characteristics and Outcomes of Patients with Newly Diagnosed De Novo Acute Myeloid Leukemia (AML) during the COVID-19 PandemicConference abstract Published on 2021-11-242022-10-05 Journal: Blood [Category] 유전자 메커니즘, [키워드] Abnormalities AML Analysis Anemia baseline board Boston Care CDC Characteristics Chemotherapy clinical clinical evaluation Cohort cohorts complex correlation COVID COVID-19 COVID-19 pandemic de novo Decline demonstrated diagnosed Diagnosis disease download driven by ELN Emergency European evaluated fibrinogen figure Fisher FLT3 Foghorn funding genetics Glaxo hyperglycemia incidence Intensive Laboratory lack less leukemia malignancy Massachusett median median age molecular Mortality Mutation myeloid Myocardial infarction Next-generation sequencing no difference no significant difference not different NPM1 other diseases outcome pandemic Patient performed Platelet presenting prognostic proportion Result Retrospective analysis risk Sex significantly lower Smith specific mutation state statistical statistically statistically significant difference stroke supportive care survival Symptom symptomatic the median Therapeutic approach total patient TP53 was obtained WBC were excluded while White blood cell Wilcoxon rank sum [DOI] 10.1182/blood-2021-149692 [Article Type] Conference abstract
The Impact of COVID-19 on Acute Myeloid Leukemia (AML) Treatment Patterns in the United States: Retrospective Analysis of an Electronic Medical Records (EMR) DatabaseConference abstract Published on 2021-11-232022-10-05 Journal: Blood [Category] 치료법, [키워드] affected age AML Analysis Cancer change Characteristics Chemotherapy Cohort cohorts Community Comparisons consolidation COVID COVID-19 COVID-19 infection criteria current database defined diagnosed Diagnosis Donor dose download eligible EMR equity Estimated figure Follow-up follow-up period healthcare Hematologic malignancy high risk hospital hospitalizations HSCT Impact impacted induction Intensive Kaplan-Meier method lack less male median myeloid outcome pandemic Patient pattern Practitioner receive receiving Record reduce reducing regimens resource resources Retrospective analysis significantly significantly increased Standard of care Stem cell transplantation survival survival curve survival rate therapy time transplantation treated Treatment venetoclax was reduced was used were assessed [DOI] 10.1182/blood-2021-147979 [Article Type] Conference abstract
Successful Treatment of Acute Myeloid Leukemia with CPX-351 in 2 Patients in the United Kingdom during the COVID-19 PandemicConference abstract Published on 2021-11-232022-10-05 Journal: Blood [Category] 치료법, [키워드] Administered AML appropriate patient approved Asymptomatic benefit blood count Bone marrow change Chemotherapy Comorbidity Complete complications consolidation COVID-19 COVID-19 infection COVID-19 pandemic CPX-351 curative intent Day declined demonstrated Diabetic diagnosed disease download drug history eligible encapsulation Europe fatigue female figure FLT3 group hemoglobin IDH2 Immunocompromised patients Immunosuppression Infection infection rate Intensive IV infusion Jazz male mutated Mutation myeloid myelosuppression nephropathy neutropenic sepsis neutrophil neutrophil count NPM1 occurred pandemic Patient PCR swab Pediatric patient Platelet positive receiving remained risk risk factor Sepsis significantly speaker SRSF2 Symptom synergistic the disease the patient The United States Tolerability treated Treatment Two patient type 2 diabetes United Kingdom White blood cell wild-type working [DOI] 10.1182/blood-2021-146524 [Article Type] Conference abstract
Low Incidence of COVID-19 Infection in Patients with Acute Myeloid Leukemia Undergoing Reduced Intensity/Venetoclax Based Treatment: Initial Results of the PACE Prospective Clinical Study from the UK Trials Acceleration ProgramConference abstract Published on 2021-11-232022-10-05 Journal: Blood [Category] 유전자 메커니즘, 임상, 치료법, [키워드] acceleration AML Analysis Asymptomatic BMS board Celgene Chemotherapy clinical clinical study clinical trial Cohort cohort of patient concerning conducted Coronavirus disease 2019 cough COVID-19 COVID-19 infection cure death defined determine Diagnosis disease download education employment estimate exacerbated Exploratory analysis Fever figure Follow-up funding Hematological malignancy higher risk hospital immune response Immunosuppression incidence incidence of COVID-19 increasingly indicate Infection information intensity Intensive Jazz MDs median age myelodysplasia myeloid Non-COVID-19 Occurrence outcome pandemic Patient patient hospitalization patients patients treated Patients with cancer PCR test positive presenting symptom Program proportion Prospective provide receiving recruited reduce regimen regimens required Result resulting risk of COVID-19 risk of death SARS-CoV2 secondary severity speaker suffered Support table Takeda tested treated patients Treatment treatment arm treatment history vaccination venetoclax were infected [DOI] 10.1182/blood-2021-146061 [Article Type] Conference abstract
Gilteritinib for Relapsed Acute Myeloid Leukaemia with FLT3 Mutation during the COVID-19 Pandemic: Real World Experience from the UK National Health ServiceConference abstract Published on 2021-11-232022-10-05 Journal: Blood [Category] 변종, [키워드] 95%CI Administered Allogeneic AML approved ASXL1 board Cell Chemotherapy clinically clinician collected Complete COVID-19 COVID-19 pandemic criteria curative database de novo disease domain dose download duplication education effective ELN European experience figure FLT3 Follow-up funding Gilteritinib haematological disorder healthcare hospital Hospital admission IDH1 IDH2 immunosuppressive infected with SARS-CoV-2 information inhibitor Intensive Jazz less majority male median median age Morphological Mortality Most patient mutated Mutation mutations myeloid National Health Service network neutropenia NHS nosocomial not differ NPM1 outcome pandemic Patient patients performance status Physicians proceed reached reducing Registered reported resource resources response Result risk RUNX1 Sequencing significantly speaker Support survival Takeda the median therapy Toxicity TP53 Transmission Treatment tyrosine United Kingdom [DOI] 10.1182/blood-2021-150169 [Article Type] Conference abstract